NASDAQ:NERV - Minerva Neurosciences, Inc.
$6.47
 $-0.05
-0.77%
4:00PM EDT
2019-07-15
Minerva Neurosciences, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system (CNS) diseases. The Company's product portfolio and indications include MIN-101 for the treatment of schizophrenia; MIN-202, for the treatment of insomnia disorder and major depressive disorder (MDD); MIN-117, for the treatment of MDD, and MIN-301 for the treatment of Parkinson's disease. MIN-101 is a compound that blocks serotonin receptors and sigma receptors, two receptors in the brain that are involved in the regulation of mood, cognition, sleep and anxiety. MIN-117 is meant to block a specific subtype of serotonin receptor called 5-hydroxytryptamine type 1A (5-HT1A). MIN-202 is a selective orexin 2 receptor antagonist. MIN-301 is a soluble recombinant form of the Neuregulin-1b1 (NRG-1b1) protein, for the treatment of Parkinson's disease. Read more at  reuters.com
sector:  health care
industry:  biotechnology
the data below are updated and published after 9pm EDT each trading day
  NERV     avg for
industry  
  avg for
sector  
42 stocks weight:  5. 38   114. 77   204. 78  
42 stocks rank:  4. 24 K 1. 44 K 810. 33  
# analyst opinions:  4. 00   13. 59   13. 86  
mean recommendation:  1. 50   2. 12   2. 04  

quick ratio:  11. 47   5. 48   1. 89  
current ratio:  11. 64   5. 85   2. 40  

target price low:  18. 00   82. 72   115. 11  
target price avg:  6. 29   104. 42   138. 02  
target price high:  7. 00   130. 64   159. 47  
1-yr high:  12. 55   110. 27   142. 72  
last close:  6. 52   85. 12   126. 54  
50-day avg:  5. 74   86. 06   122. 35  
200-day avg:  7. 69   88. 76   121. 75  
1-yr low:  4. 20   69. 26   100. 63  
volume:  355. 23 K 3. 51 M 5. 53 M
50-day avg volume:  882. 66 K 3. 21 M 4. 22 M
200-day avg volume:  333. 43 K 3. 04 M 4. 75 M

1-day return:  -1. 95 % -0. 30 % -1. 01 %
this week return:  -4. 40 % -2. 16 % -1. 35 %
12-wk return:  -7. 25 % 3. 34 % 8. 69 %
52-wk return:  -18. 90 % -1. 76 % 12. 22 %

enterprise value (EV):  180. 75 M 46. 50 B 123. 99 B
market cap:  254. 45 M 40. 77 B 109. 11 B
EBITDA:  -55. 28 M 4. 33 B 8. 19 B
enterprise multiple (EV/EBITDA):  -3. 27   5. 45   12. 05  
total debt:  399. 27 K 11. 27 B 17. 58 B
debt/equity:  0. 52   57. 36   120. 25  
net income (common):  -53. 58 M 2. 13 B 4. 27 B

shares outstanding:  39. 03 M 551. 08 M 1. 24 B
shares:  33. 54 M 559. 41 M 1. 22 B
shares short:  1. 67 M 11. 15 M 11. 94 M
shares short prior month:  1. 63 M 9. 31 M 11. 96 M
short ratio:  1. 10   5. 72   3. 43  
short % of float:  6. 77 % 6. 40 % 2. 65 %
total cash/share:  2. 03   11. 00   9. 23  
total cash:  79. 16 M 6. 03 B 6. 01 B
free cash flow:  -21. 27 M 3. 02 B 4. 96 B
operating cash flow:  -40. 61 M 3. 92 B 5. 99 B

book value:  1. 98   13. 02   27. 49  
price/book:  3. 29   4. 21   8. 80  
operating margins:  0. 00 % -380. 20 % -38. 44 %
EBITDA margins:  0. 00 % 13. 59 % 23. 24 %
profit margins:  0. 00 % 10. 94 % 14. 00 %
gross margins:  0. 00 % 36. 11 % 55. 16 %

1-yr max volatility:  0. 00 % --- ---
1-yr mean volatility:  0. 00 % 1. 50 % 1. 08 %

1-yr EPS:  -1. 38   2. 12   4. 26  
forward EPS:  -2. 00   3. 47   7. 14  
P/E:  -4. 73   2. 15   33. 17  
forward P/E:  -3. 26   -4. 03   17. 60  
PE/G:  0. 31   0. 54   0. 34  
growth:  -15. 38 % 263. 03 % 78. 34 %
earnings high:  -0. 41   0. 91   1. 70  
earnings avg:  -0. 42   0. 71   1. 58  
earnings low:  -0. 42   0. 48   1. 46  
revenue high:  -0. 00   2. 64 B 11. 26 B
revenue avg:  -0. 00   2. 58 B 11. 09 B
revenue low:  -0. 00   2. 54 B 10. 90 B
return on assets:  -22. 72 % -2. 31 % 5. 31 %
return on equity:  -53. 93 % -82. 48 % 135. 30 %

beta (1yr vs S&P500):  1. 34   1. 26   0. 91  
sharpe (1yr):  -0. 07   0. 07   0. 77  

held % insiders:  3. 79 % 6. 08 % 3. 31 %
held % institutions:  81. 12 % 78. 36 % 69. 61 %

Research more with google or yahoo!
the data below are updated and re-published at 8pm EDT after each trading day

2019-07-14 : NERV
.    105.859 =       105.859 :: --> INITIAL WEIGHT <--
.    - 1.379 =        104.48 :: earnings per-share addition
.                               --> FUNDAMENTALS <--
.    x 2.076 =        216.92 :: P/E factor
.    x 1.343 =       291.322 :: PE/G factor
.    x 1.503 =       437.901 :: beta factor
.    x 0.664 =       290.615 :: sharpe factor
.    x 2.012 =       584.781 :: current ratio factor
.    x 1.047 =       612.073 :: quick ratio factor
.    x 1.382 =       845.701 :: short ratio factor
.    x 1.037 =       876.862 :: price-to-book factor
.    x 1.004 =       880.797 :: debt-to-equity factor
.                               --> PERFORMANCE <--
.    x 2.114 =      1861.991 :: sector+industry 1-year gains factor
.    x 1.033 =      1924.178 :: industry 12-weeks return factor
.    x 1.305 =      2511.579 :: industry 2-weeks return factor
.    x 1.662 =      4173.475 :: 5-day avg > 50-day avg
.    x 0.968 =       4040.03 :: "drift" penalty 1 days ago
.    x 0.996 =       4023.55 :: "drift" penalty 2 days ago
.    / 2.092 =      1923.477 :: overall "drift" factor
.    x 0.219 =       421.831 :: largest single-day jump factor
.    x 0.094 =        39.571 :: low price factor
.    x 0.185 =         7.324 :: notable returns + performance factor
.                               --> PROJECTIONS <--
.    x 0.802 =         5.874 :: forward EPS factor
.    x 0.928 =         5.451 :: forward P/E factor
.    x 1.182 =         6.446 :: industry recommendation factor
.    x 2.642 =        17.027 :: company recommendation factor
.    x 1.008 =        17.157 :: factor historical industry gain for week 28
.   x 10.225 =       175.424 :: spline projection factor
.                               --> FINAL ADJUSTMENTS <--
.  quad root =         3.639 :: reduced for readability
.    + 1.739 =         5.378 :: add/subtract for investor sentiment
.                               --> FINAL WEIGHT <--
.                      5.378 :: FINAL WEIGHT for NASDAQ:NERV


 


News feed RSS items generated from finance.google.com

News feed formatting by feed2js.org